FOLFOX activity in a rare case of metastatic colonic adenocarcinoma of the tongue: a case report.

Related Articles

FOLFOX activity in a rare case of metastatic colonic adenocarcinoma of the tongue: a case report.

BMC Cancer. 2018 Apr 26;18(1):470

Authors: Zichi C, Tampellini M, Tucci M, Sonetto C, Baratelli C, Brizzi MP, Scagliotti GV

Abstract
BACKGROUND: Adenocarcinomas of the oral cavity are rare neoplasms, and only four cases of primary colonic adenocarcinoma of the tongue have ever been described in literature. Very few information about chemotherapy sensitiveness of this type of neoplasia is available, with only one regimen that showed some activity in a metastatic patient.
CASE PRESENTATION: We describe the case of a patient bearing a metastatic colonic adenocarcinoma of the tongue submitted to a first-line chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid (FOLFOX regimen). After chemotherapy the patient obtained the complete disappearance of the primitive neoplasia located in the body of the tongue, and a tumor size reduction > 50% of liver and lung metastases.
CONCLUSIONS: This case demonstrated the activity of the combination of oxaliplatin and 5-fluorouracil in this very rare neoplasia. The FOLFOX regimen might be considered either in advanced and especially in the neoadjuvant setting, when the reduction of the primary tumor is highly needed.

PMID: 29699528 [PubMed - in process]

https://ift.tt/2HROEMH